Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (71-80 of 420) with videos related to

Pageof 42
Sort By:
Jac-Antimicrobial Resistance|September 13, 2021
Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against <i>Pseudomonas aeruginosa</i> from cystic fibrosis patientsHelio S Sader, Leonard R Duncan, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease|October 24, 2022
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2013
Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010Susanne Paukner, Helio S Sader, Zrinka Ivezic-Schoenfeld, et al.
International Journal of Antimicrobial Agents|December 29, 2009
Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and CanadaMichael A Pfaller, Mariana Castanheira, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|October 4, 2017
Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chlorideMariana Castanheira, Leonard R Duncan, Paul R Rhomberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 2026
In vitro activity of furazidin and comparator agents against bacterial isolates from urinary tract infectionsJustyna Maszkowska, Agnieszka Denkis, Mariana Castanheira, et al.
The Journal of Infection|September 14, 2010
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)David J Farrell, Mariana Castanheira, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|December 5, 2006
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeHelio S Sader, Andre Hsiung, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2018
Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2018
Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Pageof 42

Showing results (71-80 of 420) with videos related to

Sort By:
Pageof 42
Jac-Antimicrobial Resistance|September 13, 2021
Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against <i>Pseudomonas aeruginosa</i> from cystic fibrosis patientsHelio S Sader, Leonard R Duncan, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease|October 24, 2022
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2013
Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010Susanne Paukner, Helio S Sader, Zrinka Ivezic-Schoenfeld, et al.
International Journal of Antimicrobial Agents|December 29, 2009
Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and CanadaMichael A Pfaller, Mariana Castanheira, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|October 4, 2017
Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chlorideMariana Castanheira, Leonard R Duncan, Paul R Rhomberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 2026
In vitro activity of furazidin and comparator agents against bacterial isolates from urinary tract infectionsJustyna Maszkowska, Agnieszka Denkis, Mariana Castanheira, et al.
The Journal of Infection|September 14, 2010
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)David J Farrell, Mariana Castanheira, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|December 5, 2006
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeHelio S Sader, Andre Hsiung, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2018
Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2018
Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Pageof 42